244 related articles for article (PubMed ID: 8269142)
1. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology.
Gohlke-Bärwolf C; Acar J; Burckhardt D; Oakley C; Butchart E; Krayenbühl P; Hall R; Bodnar E; Krzeminska-Pakula M; Delahaye JP
J Heart Valve Dis; 1993 Jul; 2(4):398-410. PubMed ID: 8269142
[No Abstract] [Full Text] [Related]
2. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation?
Acar J
J Heart Valve Dis; 1993 Jul; 2(4):395-7. PubMed ID: 8269141
[No Abstract] [Full Text] [Related]
3. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
[TBL] [Abstract][Full Text] [Related]
4. German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve.
Horstkotte D; Bergemann R; Althaus U; Babin-Ebell J; Chares M; Dahm M; Eigel P; Elert O; Emmrich K; Geiger AW
J Heart Valve Dis; 1993 Jul; 2(4):411-9. PubMed ID: 8269143
[No Abstract] [Full Text] [Related]
5. [Prevention of thrombosis in heart valve diseases].
Meyer BJ; Beer JH
Ther Umsch; 1998 Dec; 55(12):756-61. PubMed ID: 10025189
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.
Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhart D; Bodnar E; Hall R; Delahaye JP; Horstkotte D; Krémer R
Eur Heart J; 1995 Oct; 16(10):1320-30. PubMed ID: 8746900
[No Abstract] [Full Text] [Related]
7. Experience with moderate intensity anticoagulation and aspirin after mechanical valve replacement. A retrospective, non-randomized study.
Albertal J; Sutton M; Pereyra D; Segura EV; Aramburu DF; Lardani H; Diaz R
J Heart Valve Dis; 1993 May; 2(3):302-7. PubMed ID: 8269123
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of thromboembolism following heart valve replacement].
van de Loo J; Stenzinger W
Verh Dtsch Ges Inn Med; 1989; 95():275-82. PubMed ID: 2690497
[No Abstract] [Full Text] [Related]
9. [Anticoagulation in surgery, after hemorrhagic complications and in pregnancy].
Gohlke-Bärwolf C
Z Kardiol; 1998; 87 Suppl 4():56-62. PubMed ID: 9857468
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
Duveau D
Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
[No Abstract] [Full Text] [Related]
11. [Long-term oral coagulation. Self monitoring prevents complication].
MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
[No Abstract] [Full Text] [Related]
12. High complication and failure rates of anticoagulant therapy are unavoidable.
Nitter-Hauge S; Dale J
Z Kardiol; 1986; 75 Suppl 2():293-7. PubMed ID: 3727705
[No Abstract] [Full Text] [Related]
13. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of thromboembolism in heart valve diseases and following heart valve replacement].
Stenzinger W; van de Loo J
Internist (Berl); 1989 Aug; 30(8):520-4. PubMed ID: 2676892
[No Abstract] [Full Text] [Related]
15. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
[TBL] [Abstract][Full Text] [Related]
17. High complication and failure rates of anticoagulant therapy are avoidable.
Broekmans AW; Loeliger EA
Z Kardiol; 1986; 75 Suppl 2():298-301. PubMed ID: 3727706
[No Abstract] [Full Text] [Related]
18. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
Dale J; Nitter-Hauge S
Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
[No Abstract] [Full Text] [Related]
19. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
[TBL] [Abstract][Full Text] [Related]
20. [Optimizing long-term anticoagulation by patient self-management?].
Bernardo A
Z Kardiol; 1998; 87 Suppl 4():75-81. PubMed ID: 9857471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
